Search for the latest oncology news by tumour type
Findings from a preclinical study led by VHIO’s Models of Cancer Therapies Group, directed by…
Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing…
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
On November 18, 2025, the Food and Drug Administration approved epcoritamab-bysp with lenalidomide and rituximab for…
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast…
Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from…
Researchers at the UCLA Health Jonsson Comprehensive Cancer Centre, USA, have identified a small molecule…
A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell…
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College…